Chronic Lung Conditions: Integrative Approaches to Long-Term Care

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Respiratory Medicine".

Deadline for manuscript submissions: 25 May 2025 | Viewed by 1800

Special Issue Editor


E-Mail Website
Guest Editor
1. Pulmonary Department, Faculty of General Medicine, University of Medicine and Pharmacy “Grigore T. Popa”, 700115 Iasi, Romania
2. Clinical Hospital of Pulmonary Diseases Iași, 700116 Iasi, Romania
Interests: chronic pulmonary disease management; tobacco use and cessation; tuberculosis; interstitial lung diseases; post-COVID-19 respiratory implications; air pollution impact on respiratory health; pulmonary rehabilitation; severe asthma; COPD multimorbidity; interventional bronchoscopy techniques and training
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Currently, numerous categories of health professionals are raising awareness of the increasing burden of chronic lung conditions. It is supposed that this status quo will continue to be a major concern in the context of global climate change, environmental air pollution, and tobacco and TB endemics, causing various issues to respiratory health—not to mention the recent COVID-19 pandemic that is still not fully understood regarding its long-term impact on the lungs. This Special Issue of the Journal of Clinical Medicine aims to highlight the major research gaps and progress in the broad area defined as chronic lung conditions. Its goal is to accentuate the need for an integrative approach of these entities, as well as to point out the benefits of long-term care for chronic lung disease course and treatment outcomes.

Prof. Dr. Antigona Carmen Trofor
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • chronic lung conditions: chronic non-infectious lung disease and post-respiratory infectious syndromes, including TB sequelae, TB MDR, post-COVID-19, and bronchiectasis
  • long-term care
  • integrative approach
  • multidisciplinary
  • multimorbidity
  • outcomes

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

23 pages, 715 KiB  
Article
SMART Multi-Criteria Decision Analysis (MCDA)—One of the Keys to Future Pandemic Strategies
by Gianina-Valentina Băcescu Ene, Mirela-Anca Stoia, Cristian Cojocaru and Doina Adina Todea
J. Clin. Med. 2025, 14(6), 1943; https://doi.org/10.3390/jcm14061943 - 13 Mar 2025
Viewed by 680
Abstract
Background/Objectives: The COVID-19 pandemic underscored the need for adaptive public health strategies and effective decision-making tools to optimize clinical responses and policy measures based on regional contexts. This study aims to identify key criteria for developing a patient-centered strategy to enhance the resilience [...] Read more.
Background/Objectives: The COVID-19 pandemic underscored the need for adaptive public health strategies and effective decision-making tools to optimize clinical responses and policy measures based on regional contexts. This study aims to identify key criteria for developing a patient-centered strategy to enhance the resilience of Romania’s healthcare system during the pandemic. Methods: This research introduces a Multi-Criteria Decision Analysis (MCDA) model using the Simple Multiple Attribute Assessment Technique (SMART) to integrate quantitative and qualitative data, providing decision-makers with a structured tool for improving healthcare resilience. A survey of 412 Romanian healthcare professionals identified critical risks and opportunities. The study followed a two-phase approach: first, analyzing expert perceptions to determine key challenges; second, applying a mixed-methods evaluation to prioritize resilience-building strategies. Results: Four main challenges emerged: (1) healthcare workforce shortages causing excessive workload and stress, (2) poor communication and systemic inefficiencies limiting patient access, (3) weak crisis management due to delayed control measures, and (4) regulatory gaps leading to fragmented responses. Proposed solutions included workforce training, improved communication, telemedicine integration, increased financial support, and a unified legal framework. The SMART method facilitated the structured prioritization of these measures, with long-term system sustainability emerging as the most effective strategy for preventing future crises. Conclusions: This study demonstrates the value of integrating MCDA into healthcare decision-making, offering a scalable model for policymakers to enhance crisis response and resource allocation. By incorporating expert insights and patient needs, the proposed framework strengthens healthcare system preparedness, contributing to informed, patient-centered decision-making and long-term resilience. Ultimately, our findings not only contribute to the existing literature but may also open new directions to facilitate informed, patient-centered decision making, thereby strengthening the resilience of healthcare systems in crisis situations. Full article
(This article belongs to the Special Issue Chronic Lung Conditions: Integrative Approaches to Long-Term Care)
Show Figures

Figure 1

14 pages, 1573 KiB  
Article
Metabolic Disturbances Associated with In-Hospital Complication and Mortality in Different Types of Pneumonia
by Iulia Făgărășan, Adriana Rusu, Horațiu Comșa, Maria Cristea, Nicoleta-Ștefania Motoc, Ciprian Cristea, Corina Eugenia Budin, Ruxandra-Mioara Râjnoveanu and Doina Adina Todea
J. Clin. Med. 2024, 13(24), 7832; https://doi.org/10.3390/jcm13247832 - 22 Dec 2024
Viewed by 755
Abstract
Bakground: The mortality rate from community-acquired pneumonia (CAP) or coronavirus disease 19 (COVID-19) is high, especially in hospitalized patients. This study aimed to assess the disturbances of glucose and lipid metabolism with in-hospital complications and short-term outcomes for patients with pneumonia with different [...] Read more.
Bakground: The mortality rate from community-acquired pneumonia (CAP) or coronavirus disease 19 (COVID-19) is high, especially in hospitalized patients. This study aimed to assess the disturbances of glucose and lipid metabolism with in-hospital complications and short-term outcomes for patients with pneumonia with different etiologies. Methods: This observational study comprised 398 patients divided as follows: 155 with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia, 129 participants with viral CAP, and 114 with bacterial pneumonia. Results: Fasting plasma glucose (FPG) at admission and glycemic variation during hospitalization was linked with acute kidney injury (AKI) in bacterial CAP. Compared with a value <110 mg/dL for FPG at admission, levels between 110 and 126 mg/dL are associated with mortality in both COVID-19 (OR = 3.462, 95% CI: 1.275–9.398, p = 0.015) and bacterial CAP participants (OR = 0.254; 95% CI: 0.069–0.935, p = 0.039), while a value ≥126 mg/dL was linked with mortality only in patients with SARS-CoV-2 (OR = 3.577, 95% CI: 1.166–10.976, p = 0.026). No relation between lipid biomarkers and complications or in-hospital outcomes was observed in all three participant groups. Conclusions: Patients with bacterial CAP are more prone to developing AKI due to increased FBG at admission and glycemic variations during hospitalization, while elevated FBG values at admission are associated with mortality in both COVID-19 and bacterial CAP. Full article
(This article belongs to the Special Issue Chronic Lung Conditions: Integrative Approaches to Long-Term Care)
Show Figures

Figure 1

Back to TopTop